Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

Human Pathology

Volumn 44, Issue 2, 2013, Pages 244-254

  Romero Pérez, Laura ^a   Castilla, María Ángeles ^a   López García, María Ángeles ^a   Díaz Martín, Juan ^a   Biscuola, Michele ^a   Ramiro Fuentes, Susana ^a   Oliva, Esther ^b   Matias Guiu, Xavier ^c   Prat, Jaime ^d   Cano, Amparo ^e   Moreno Bueno, Gema ^e,f   Palacios, José ^a,g  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^d HOSPITAL SANT PAU   (Spain)

^e CSIC   (Spain)

^f MD ANDERSON CANCER CENTER   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Endometrial carcinosarcoma; HMGA2; let 7b; Lin28B

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; NY ESO 1 ANTIGEN; TUMOR ANTIGEN;

ARTICLE; CARCINOGENESIS; DNA MICROARRAY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MUSCLE DEVELOPMENT; TUMOR DIFFERENTIATION;

CARCINOMA, ENDOMETRIOID; CARCINOSARCOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA2 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872679777     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.05.013     Document Type: Article

References (35)

1. E. D'Angelo, and J. Prat Uterine sarcomas: a review Gynecol Oncol 116 2010 131 139
2. M.A. Lopez-Garcia, and J. Palacios Pathologic and molecular features of uterine carcinosarcomas Semin Diagn Pathol 27 2010 274 286
3. W.G. McCluggage Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas Int J Gynecol Cancer 12 2002 687 690 (Pubitemid 35388035)
4. S.F. Lax Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium Pathology 39 2007 46 54
5. W.B. Growdon, B.N. Roussel, and V.L. Scialabba Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin Gynecol Oncol 121 2011 212 217
6. M.A. Castilla, G. Moreno-Bueno, and L. Romero-Perez Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma J Pathol 223 2011 72 80
7. D. Sarrio, S.M. Rodriguez-Pinilla, D. Hardisson, A. Cano, G. Moreno-Bueno, and J. Palacios Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype Cancer Res 68 2008 989 997 (Pubitemid 351272216)
8. M. Zeisberg, and E.G. Neilson Biomarkers for epithelial-mesenchymal transitions J Clin Invest 119 2009 1429 1437
9. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumor progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7 2007 415 428 (Pubitemid 46809165)
10. G. Moreno-Bueno, F. Portillo, and A. Cano Transcriptional regulation of cell polarity in EMT and cancer Oncogene 27 2008 6958 6969
11. R. Reeves, D.D. Edberg, and Y. Li Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells Mol Cell Biol 21 2001 575 594 (Pubitemid 32037376)
12. R. Sgarra, A. Rustighi, and M.A. Tessari Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer FEBS Lett 574 2004 1 8 (Pubitemid 39200885)
13. N. Montserrat, A. Mozos, and D. Llobet Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma Hum Pathol 43 2012 632 643
14. S.M. Park, S. Shell, and A.R. Radjabi Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 Cell Cycle 2007 2585 2590 (Pubitemid 350224037)
15. I. Heo, C. Joo, J. Cho, M. Ha, J. Han, and V.N. Kim Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA Mol Cell 32 2008 276 284
16. A. Helland, M.S. Anglesio, and J. George Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers PLoS One 6 2011 e18064
17. U. Leppert, W. Henke, X. Huang, J.M. Muller, and W. Dubiel Post-transcriptional fine-tuning of COP9 signalosome subunit biosynthesis is regulated by the c-Myc/Lin28B/let-7 pathway J Mol Biol 409 2011 710 721
18. G.L. Maxwell, G.V. Chandramouli, and L. Dainty Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer Clin Cancer Res 11 2005 4056 4066 (Pubitemid 40791569)
19. F. Bertucci, P. Finetti, and N. Cervera Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers Cancer Res 66 2006 4636 4644
20. Cancer Genome Atlas Research N Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
21. J.I. Risinger, G.V. Chandramouli, and G.L. Maxwell Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression Clin Cancer Res 13 2007 1713 1719 (Pubitemid 46952936)
22. S. Vatolin, Z. Abdullaev, and S.D. Pack Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes Cancer Res 65 2005 7751 7762 (Pubitemid 41297250)
23. D. Loukinov, A. Ghochikyan, and M. Mkrtichyan Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant J Cell Biochem 98 2006 1037 1043 (Pubitemid 44128346)
24. S. Thuault, E.J. Tan, H. Peinado, A. Cano, C.H. Heldin, and A. Moustakas HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition J Biol Chem 283 2008 33437 33446
25. C. Mayr, M.T. Hemann, and D.P. Bartel Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation Science 315 2007 1576 1579 (Pubitemid 46449474)
26. A. Mahajan, Z. Liu, and L. Gellert HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma Mod Pathol 23 2010 673 681
27. C.E. King, M. Cuatrecasas, A. Castells, A.R. Sepulveda, J.S. Lee, and A.K. Rustgi LIN28B promotes colon cancer progression and metastasis Cancer Res 71 2011 4260 4268
28. Y.C. Wang, Y.L. Chen, and R.H. Yuan Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma Carcinogenesis 31 2010 1516 1522
29. E.F. Schoenmakers, S. Wanschura, R. Mols, J. Bullerdiek, H. Van den Berghe, and W.J. Van de Ven Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors Nat Genet 10 1995 436 444
30. J. Miyazawa, A. Mitoro, S. Kawashiri, K.K. Chada, and K. Imai Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity Cancer Res 64 2004 2024 2029 (Pubitemid 38339449)
31. A. Fusco, and M. Fedele Roles of HMGA proteins in cancer Nat Rev Cancer 7 2007 899 910 (Pubitemid 350165857)
32. F. Di Cello, J. Hillion, and A. Hristov HMGA2 participates in transformation in human lung cancer Mol Cancer Res 6 2008 743 750
33. K. Motoyama, H. Inoue, Y. Nakamura, H. Uetake, K. Sugihara, and M. Mori Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family Clin Cancer Res 14 2008 2334 2340 (Pubitemid 351551065)
34. J. Wu, Z. Liu, and C. Shao HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes Cancer Res 71 2011 349 359
35. W.G. McCluggage, L.E. Connolly, H.A. McBride, S. Kalloger, and C.B. Gilks HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis Histopathology 60 2012 547 553